Mistrial Declared after Jury Deadlocks in Illinois Zantac Prostate Cancer Case

CHICAGO — An Illinois state jury has deadlocked in a trial in which a man alleges he developed prostate cancer as a result of taking Zantac (ranitidine) that was contaminated with high levels of N-Nitrosodimethylamine (NDMA), a potent carcinogen.

A Cook County (Ill.) Circuit Court judge declared a mistrial on Aug. 7 in the case, in which plaintiff Martin Gross accused Boehringer Ingelheim Pharmaceuticals Inc. of failing to warn consumers of the risk and of failing to caution retailers or customers to refrigerate Zantac, which would have kept it from converting into NDMA.

Gross alleges that he used Zantac from …